OtherFamily Medicine — World Perspective

Clinical Depressive Symptoms and Diabetes in a Binational Border Population

Nelda Mier, Anabel Bocanegra-Alonso, Dongling Zhan, Suojin Wang, Steven M. Stoltz, Rosa I. Acosta-Gonzalez and Miguel A. Zuniga
The Journal of the American Board of Family Medicine May 2008, 21 (3) 223-233; DOI: https://doi.org/10.3122/jabfm.2008.03.070255

References

  1. ↵
    Antai-Otong D. Diabetes and depression: pharmacologic considerations. Perspect Psychiatr Care 2007; 43: 93–6.
    OpenUrlPubMed
  2. ↵
    Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002; 25: 464–70.
    OpenUrlAbstract/FREE Full Text
  3. Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28: 2668–72.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    de Groot M, Doyle T, Hockman E, et al. Depression among type 2 diabetes rural Appalachian clinic attendees. Diabetes Care 2007; 30: 1602–4.
    OpenUrlFREE Full Text
  5. ↵
    Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069–78.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    de Groot M, Pinkerman B, Wagner J, Hockman E. Depression treatment and satisfaction in a multicultural sample of type 1 and type 2 diabetic patients. Diabetes Care 2006; 29: 549–53.
    OpenUrlAbstract/FREE Full Text
  7. Centers for Disease Control and Prevention. Serious psychological distress among persons with diabetes New York City, 2003. MMWR Morb Mortal Wkly Rep 2004; 53: 1089–92.
    OpenUrlPubMed
  8. ↵
    Spencer MS, Kieffer EC, Sinco BR, et al. Diabetes-specific emotional distress among African Americans and Hispanics with type 2 diabetes. J Health Care Poor Underserved 2006; 17(Suppl): 88–105.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Georgiades A, Zucker N, Friedman KE, et al. Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med 2007; 69: 235–41.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Centers for Disease Control and Prevention. Fact sheet. Prevalence of diabetes among Hispanics in six US geographic locations. 2005. Available at http://www.cdc.gov/diabetes/pubs/factsheets/hispanic.htm. Accessed 13 March 2008.
  11. ↵
    Prevalence of diabetes among Hispanics–selected areas, 1998–2002. MMWR Morb Mortal Wkly Rep 2004; 53: 941–4.
    OpenUrlPubMed
  12. ↵
    Simon P, Zeng Z, Wold C, Fielding J, Burrows N. Diabetes among Hispanics Los Angeles County. California, 2002–2003. MMWR Morb Mortal Wkly Rep 2003; 52: 1152–5.
    OpenUrlPubMed
  13. ↵
    Caballero AE. Diabetes in the Hispanic or Latino population: genes, environment, culture, and more. Curr Diab Rep 2005; 5: 217–25.
    OpenUrlCrossRefPubMed
  14. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care 2003; 26: 1435–8.
    OpenUrlAbstract/FREE Full Text
  15. Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A US population study. Diabetes Care 1998; 21: 1230–5.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diabetes Care 1993; 16: 1446–52.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Pan-American Health Organization, The Centers for Disease Control and Prevention. The US-Mexico Border Diabetes Prevention and Control Project. First report of results. Available at http://www.fep.paho.org/english/publicaciones/Diabetes/Diabetes%20first%20report%20of%20Results.pdf. Accessed 13 March 2008.
  18. ↵
    Centers for Disease Control and Prevention. QuickStats: Diabetes death rate* for Hispanics† compared with Non-Hispanic Whites    United States versus counties along the US-Mexico border, 2000–2002. MMWR 2006; 55: 882.
    OpenUrl
  19. ↵
    Rull JA, Aguilar-Salinas CA, Rojas R, Rios-Torres JM, Gomez-Perez FJ, Olaiz G. Epidemiology of type 2 diabetes in Mexico. Arch Med Res 2005; 36: 188–96.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    Olaiz-Fernández G, Rojas R, Aguilar-Salinas CA, Rauda J, Villalpando S. Diabetes mellitus en adultos mexicanos. Resultados de la Encuesta Nacional de Salud 2000. Salud Pub Mex 2007; 29(Suppl 3): S331–7.
    OpenUrl
  21. ↵
    Goodnick PJ, Henry JH, Buki VM. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 1995; 56: 128–36.
    OpenUrlPubMedWeb of Science
  22. ↵
    de Groot M, Jacobson AM, Samson JA, Welch G. Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychom Res 1995; 46: 425–35.
    OpenUrl
  23. ↵
    Fisher L, Chesla CA, Mullan JT, Skaff MM, Kanter RA. Contributors to depression in Latino and European-American patients with type 2 diabetes. Diabetes Care 2001; 24: 1751–7.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Shah ZC, Huffman FG. Depression among Hispanic women with type 2 diabetes. Ethn Dis 2005; 15: 685–90.
    OpenUrlPubMedWeb of Science
  25. ↵
    Garcia de Alba Garcia JE, Dallo FJ, Salcedo Rocha AL, et al. The relative effect of self-management practices on glycaemic control in type 2 diabetic patients in Mexico. Chronic Illn 2006; 2: 77–85.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Gross R, Olfson M, Gameroff MJ, et al. Depression and glycemic control in Hispanic primary care patients with diabetes. J Gen Intern Med 2005; 20: 460–6.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    Killilea T. Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care. Am J Manag Care 2002; 8(Suppl): S441–9.
    OpenUrlPubMedWeb of Science
  28. ↵
    United States-Mexico Border Health Commission. Healthy border 2010. An agenda for improving health on the United States-Mexico border. El Paso (TX): United States-Mexico Border Health Commission; 2003.
  29. ↵
    Boyd JH, Weissman MM, Thompson W, Myers JK. Screening for depression in a community sample. Arch Gen Psychiat 1982; 39: 1195–200.
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    Roberts RE, Vernon SW. The Center for Epidemiologic Studies Depression Scale: its use in a community sample. Am J Psychiatry 1983; 140: 41–6.
    OpenUrlPubMedWeb of Science
  31. ↵
    Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 2005; 19: 113–22.
    OpenUrlPubMedWeb of Science
  32. ↵
    Garcia M, Marks G. Depressive symptomatology among Mexican-American adults: an examination with the CES-D Scale. Psychiatry Res 1989; 27: 137–48.
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    Roberts RE. Reliability of the CES-D scale in different ethnic contexts. Psychiatry Res 1980; 2: 125–34.
    OpenUrlCrossRefPubMedWeb of Science
  34. ↵
    Powers MG. Measures of socioeconomic status: an introduction. In: Powers MG (ed). Measures of socioeconomic status: current issues. Boulder (CO): Westview; 1981: 1–28.
  35. ↵
    Krieger N, Williams DR, Moss NE. Measuring social class in U.S. public health research: concepts, methodologies, and guidelines. Annu Rev Public Health 1997; 18: 341–78.
    OpenUrlCrossRefPubMedWeb of Science
  36. ↵
    Marin G, Sabogal F, Marin BV, Otero-Sabogal R, Perez-Stable EJ. Development of a short acculturation scale for Hispanics. Hispanic Behav Sci 1987; 9: 183–205.
    OpenUrl
  37. ↵
    Hoogwerf B. Diabetes Form 2.1. Minneapolis (MN): InterStudy; 1989.
  38. ↵
    Glasgow R, Toobert D. Social environment and regimen adherence among type II diabetic patients. Diabetes Care 1988; 11: 377–86.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    SPSS Inc. Statistical Package for the Social Sciences (SPSS) for Windows, Rel. 13.0 2004. Chicago (IL): SPSS, Inc.; 2004.
  40. ↵
    Black SA, Markides KS, Miller TQ. Correlates of depressive symptomatology among older community-dwelling Mexican Americans: the Hispanic EPESE. J Gerontol B Psychol Sci Soc Sci 1998; 53: S198–208.
    OpenUrlPubMedWeb of Science
  41. ↵
    Black SA. Increased health burden associated with comorbid depression in older diabetic Mexican Americans. Results from the Hispanic Established Population for the Epidemiologic Study of the Elderly survey. Diabetes Care 1999; 22: 56–64.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Téllez-Zenteno JF, Cardiel MH. Risk factors associated with depression in patients with type 2 diabetes mellitus. Arch Med Res 2002; 33: 53–60.
    OpenUrlCrossRefPubMedWeb of Science
  43. ↵
    Garduño-Espinosa J, Téllez-Zenteno JF, Hernández-Ronquillo L. Frequency of depression in patients with diabetes mellitus type 2. Rev Invest Clin 1998; 50: 287–91.
    OpenUrlPubMed
  44. ↵
    McKellar JD, Humphreys K, Piette JD. Depression increases diabetes symptoms by complicating patients’ self-care adherence. Diabetes Educ 2004; 30: 485–92.
    OpenUrlFREE Full Text
  45. Sacco WP, Yanover T. Diabetes and depression: the role of social support and medical symptoms. J Behav Med 2006; 29: 523–31.
    OpenUrlCrossRefPubMedWeb of Science
  46. Ludman EJ, Katon W, Russo J, et al. Depression and diabetes symptom burden. Gen Hosp Psychiatry 2004; 26: 430–6.
    OpenUrlCrossRefPubMedWeb of Science
  47. ↵
    Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry 2003; 25: 246–52.
    OpenUrlCrossRefPubMedWeb of Science
  48. ↵
    Katon W, von Korff M, Ciechanowski P, et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 2004; 27: 914–20.
    OpenUrlAbstract/FREE Full Text
  49. Fisher L, Chesla CA, Skaff MM, Mullan JT, Kanter RA. Depression and anxiety among partners of European-American and Latino patients with type 2 diabetes. Diabetes Care 2002; 25: 1564–70.
    OpenUrlAbstract/FREE Full Text
  50. ↵
    Blazer DG, Moody-Ayers S, Craft-Morgan J, Burchett B. Depression in diabetes and obesity: racial/ethnic/gender issues in older adults. J Psychosom Res 2002; 53: 913–6.
    OpenUrlCrossRefPubMed
  51. ↵
    Heisler M, Piette JD, Spencer M, Kieffer E, Vijan S. The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care 2005; 28: 816–22.
    OpenUrlAbstract/FREE Full Text
  52. ↵
    Egede LE. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry 2007; 29: 409–16.
    OpenUrlCrossRefPubMedWeb of Science
  53. Husaini BA, Hull PC, Sherkat DE, et al. Diabetes, depression, and healthcare utilization among African Americans in primary care. J Natl Med Assoc 2004; 96: 476–84.
    OpenUrlPubMed
  54. ↵
    Kalsekar ID, Madhavan SM, Amonkar MM, Scott V, Douglas SM, Makela E. The effect of depression on health care utilization and costs in patients with type 2 diabetes. Manag Care Interface 2006; 19: 39–46.
    OpenUrlPubMed
  55. ↵
    Franciosi M, Pellegrini F, De Berardis G, et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care 2001; 24: 1870–7.
    OpenUrlAbstract/FREE Full Text
  56. ↵
    Siebolds M, Gaedeke O, Schwedes U. Self-monitoring of blood glucose–psychological aspects relevant to changes in HbA1c in type 2 diabetic patients treated with diet or diet plus oral antidiabetic medication. Patient Educ Couns 2006; 62: 104–10.
    OpenUrlCrossRefPubMed
  57. Halimi S, Wion-Barbot N, Lambert S, Benhamou P. Self-monitoring of blood glucose in type 2 diabetic patients. What could we propose according to their treatment? Diabetes Metab 2003; 29(2 Pt 2): S26–30.
    OpenUrlPubMed
  58. ↵
    Schwedes U, Siebolds M, Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002; 25: 1928–32.
    OpenUrlAbstract/FREE Full Text
  59. ↵
    Brunner J, Parhofer KG, Schwandt P, Bronisch T. Cholesterol, essential fatty acids, and suicide. Pharmacopsychiatry 2002; 35: 1–5.
    OpenUrlCrossRefPubMed
  60. Tatley M, Savage R. Psychiatric adverse reactions with statins, fibrates and ezetimibe: implications for the use of lipid-lowering agents. Drug Saf 2007; 30: 195–201.
    OpenUrlCrossRefPubMedWeb of Science
  61. ↵
    Golomb BA, Criqui MH, White HL, Dimsdale JE. The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes. Control Clin Trials 2004; 25: 178–202.
    OpenUrlCrossRefPubMedWeb of Science
  62. ↵
    Tsai SJ. Statins may enhance the proteolytic cleavage of proBDNF: implications for the treatment of depression. Med Hypotheses 2007; 68: 1296–9.
    OpenUrlCrossRefPubMedWeb of Science
  63. ↵
    Young-Xu Y, Chan KA, Liao JK, Ravid S, Blatt CM. Long-term statin use and psychological well-being. J Am Coll Cardiol 2003; 42: 690–7.
    OpenUrlCrossRefPubMedWeb of Science
  64. ↵
    Lustman PJ, Williams MM, Sayuk GS, Nix BD, Clouse RE. Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care 2007; 30: 459–66.
    OpenUrlAbstract/FREE Full Text
  65. ↵
    Kruse J, Petrak F, Herpertz S, Albus C, Lange K, Kulzer B. Diabetes and depression-a life-endangering interaction. Z Psychosom Med Psychother 2006; 52: 289–309.
    OpenUrlPubMed
  66. ↵
    Homedes N, Ugalde A. Globalization and health at the United States-Mexico border. Am J Public Health 2003; 93: 2016–22.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section